Figure 2.
Planar nuclear scintigraph of the distribution of 177Lu-DOTA-8AOC-BBN(7-14)NH2 obtained 48 hours post radiopharmaceutical administration in a PC-3 human prostate tumor xenografted SCID mouse. The areas of highest focal intensity of 177Lu-DOTA-8AOC-BBN(7-14)NH2 correspond to PC-3 xenograft location.